Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities. (2022)

First Author: Tabrizi SJ
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(22)00121-1

PubMed Identifier: 35716694

Publication URI: http://europepmc.org/abstract/MED/35716694

Type: Journal Article/Review

Volume: 21

Parent Publication: The Lancet. Neurology

Issue: 7

ISSN: 1474-4422